Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

By virtue of the notified concentration, EQT VII (controlled by EQT Fund Management S.à.r.l) intends to acquire sole control over Curaeos Holding B.V. within the meaning of Article 3(1)(b) of the EU Merger Regulation.

EQT VII was launched in 2015 with commitments of approximately EUR 6.75 billion. The fund seeks to make investments primarily in Northern Europe. EQT VII is part of the EQT group of private equity funds.

Curaeos Holding B.V. is the parent company of an international dental services group with dental clinics in the Netherlands, Belgium, Denmark, Germany and Italy. In addition, Curaeos owns a dental labs business with labs in the Netherlands, Denmark and Germany and a significant stake in a manufacturing joint venture in China, supplying both external (third party) customers and dental clinics within Curaeos.

Curaeos also owns a dental products distribution business supplying various third party dental materials products to external (third party) customers and Curaeos's own dental clinics and labs in the Netherlands, Belgium and Denmark.